Decreased levels of angiogenic growth factors in intracranial atherosclerotic disease despite severity-related increase in endothelial progenitor cell counts

Cerebrovascular Diseases

Volumn 35, Issue 1, 2013, Pages 81-88

  Massot, A ^a   Navarro Sobrino, M ^a   Penalba, A ^a   Arenillas, J F ^b   Giralt, D ^a   Ribo M ^a   Molina, C A ^a   Alvarez Sabin J ^a   Montaner, J ^a   Rosell, A ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Atherosclerosis; Endothelial progenitor cells; Growth factors; Intracranial stenosis; Stenosis severity

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR BB; SCATTER FACTOR; VASCULOTROPIN; ANGIOGENIC FACTOR; HYDROCORTISONE; PLATELET DERIVED GROWTH FACTOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; BRAIN PERFUSION; CELL COUNT; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; INTRACRANIAL ATHEROSCLEROTIC DISEASE; MALE; NEUROLOGIC EXAMINATION; OCCLUSIVE CEREBROVASCULAR DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN MICROARRAY; TRANSIENT ISCHEMIC ATTACK; HYDROCORTISONE BLOOD LEVEL; STENOSIS; TRANSCRANIAL DOPPLER;

AGED; ANALYSIS OF VARIANCE; ANGIOGENIC PROTEINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL COUNT; DOWN-REGULATION; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEIN ARRAY ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STEM CELLS; STROKE; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84875159519     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000346097     Document Type: Article

References (40)

1. Sacco R, Kargman DE, Quiong Gu, Zamanillo MC: Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995; 26: 14-20.
2. Wong KS, Huang YN, Gao S, Lam WWM, Chan YL, Kay R: Intracranial stenosis in Chinese patients with acute stroke. Neurology 1998; 50: 812-813.
3. Thomas GN, Chen XY, Lin JW, Tomlinson B, Lam WW, Liu R, et al: Middle cerebral artery stenosis increased the risk of vascular disease mortality among type diabetic patients. Cerebrovasc Dis 2008; 25: 261-267.
4. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al, Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators: Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005; 352: 1305-1316.
5. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al: Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011; 365: 993- 1003.
6. Roquer J, Segura T, Serena J, Castillo J: Endothelial dysfunction, vascular disease and stroke: the ARTICO study. Cerebrovasc Dis 2009; 27(suppl 1): 25-37.
7. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
8. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
9. Navarro-Sobrino M, Rosell A, Hernandez- Guillamon M, Penalba A, Ribó M, Alvarez- Sabín J, et al: Mobilization, endothelial differentiation and functional capacity of endothelial progenitor cells after ischemic stroke. Microvasc Res 2010; 80: 317-323.
10. Rehman J, Li J, Orschell CM, March KL: Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003; 107: 1164-1169.
11. Zhang Y, Ingram DA, Murphy MP, Saadatzadeh MR, Mead LE, Prater DN, et al: Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells. Am J Physiol Heart Circ Physiol 2009; 296: 1675- 1682.
12. Lasala GP, Silva JA, Kusnick BA, Minguell JJ: Combination stem cell therapy for the treatment of medically refractory coronary ischemia: a phase I study. Cardiovasc Revasc Med 2011; 12: 29-34.
13. Ghani U, Shuaib A, Salam A, Nasir A, Shuaib U, Jeerakathil T, et al: Endothelial progenitor cells during cerebrovascular disease. Stroke 2005; 36: 151-153.
14. Taguchi A, Matsuyama T, Moriwaki H, Hayashi T, Hayashida K, Nagatsuka K, et al: Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 2004; 109: 2972-2975.
15. Yip HK, Chang LT, Chang WN, Lu CH, Liou CW, Lan MY, et al: Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke 2008; 39: 69-74.
16. Lau KK, Chan YH, Yiu KH, Li SW, Tam S, Lau CP, et al: Burden of carotid atherosclerosis in patients with stroke: relationships with circulating endothelial progenitor cells and hypertension. J Hum Hypertens 2007; 21: 445-451.
17. Arenillas JF, Molina CA, Chacón P, Rovira A, Montaner J, Coscojuela P, et al: High lipoprotein (a), diabetes and the extent of symptomatic intracranial atherosclerosis. Neurology 2004; 63: 27-32.
18. Arenillas JF, Álvarez-Sabín J, Molina CA, Chacón P, Montaner J, Rovira A, et al: C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 2003; 34: 2463- 2468.
19. Arenillas JF, Massot A, Alvarez-Sabín J, Fernandez- Cadenas I, del Rio-Espinola A, Chacon P, et al: C-reactive protein gene C1444T polymorphism and risk of recurrent ischemic events in patients with symptomatic intracranial atherostenoses. Cerebrovasc Dis 2009; 28: 95-102.
20. Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W, et al: Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004; 24: 1246-1252.
21. George J, Shmilovich H, Deutsch V, Miller H, Keren G, Roth A: Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng 2006; 12: 331-335.
22. Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A: Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 2008; 197: 496-503.
23. Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kämper U, et al: Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981-2987.
24. Liman TG, Endres M: New vessels after stroke: postischemic neovascularization and regeneration. Cerebrovasc Dis 2012; 33: 492- 499.
25. Fadini GP, de Kreutzenberg S, Agostini C, Boscaro E, Tiengo A, Dimmeler S, et al: Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. Atherosclerosis 2009; 207: 213- 219.
26. Cesari F, Nencini P, Nesi M, Caporale R, Giusti B, Abbate R, et al: Bone marrow-derived progenitor cells in the early phase of ischemic stroke: relation with stroke severity and discharge outcome. J Cereb Blood Flow Metab 2009; 29: 1983-1990.
27. Bogoslovsky T, Chaudhry A, Latour L, Maric D, Luby M, Spatz M, et al: Endothelial progenitor cells correlate with lesion volume and growth in acute stroke. Neurology 2010; 75: 2059-2062.
28. Miller-Kasprzak E, Jagodziński PP: Endothelial progenitor cells as a new agent contributing to vascular repair. Arch Immunol Ther Exp (Warsz) 2007; 55: 247-259.
29. Bulut D, Albrecht N, Imöhl M, Günesdogan B, Bulut-Streich N, Börgel J, et al: Hormonal status modulates circulating endothelial progenitor cells. Clin Res Cardiol 2007; 96: 258-263.
30. Rafat N, Beck GCh, Peña-Tapia PG, Schmiedek P, Vajkoczy P: Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease. Stroke 2009; 40: 432-438.
31. Ni G, Liu W, Huang X, Zhu S, Yue X, Chen Z, et al: Increased levels of circulating SDF-1α and CD34(+) CXCR4(+) cells in patients with moyamoya disease. Eur J Neurol 2011; 18: 1304-1309.
32. Akita T, Murohara T, Ikeda H, Sasaki K, Shimada T, Egami K, et al: Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Lab Invest 2003; 83: 65-73.
33. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, et al: Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 7: 575-583.
34. Guo H, Huang L, Cheng M, Jin X, Zhao Y, Yi M: Serial measurement of serum basic fibroblast growth factor in patients with acute cerebral infarction. Neurosci Lett 2006; 393: 56-59.
35. Koolwijk P, van Erck MG, de Vree WJ, Vermeer MA, Weich HA, Hanemaaijer R, et al: Cooperative effect of TNFα, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J Cell Biol 1996; 132: 1177-1188.
36. Sobrino T, Pérez-Mato M, Brea D, Rodríguez- Yáñez M, Blanco M, Castillo J: Temporal profile of molecular signatures associated with circulating endothelial progenitor cells in human ischemic stroke. J Neurosci Res 2012; 90: 1788-1793.
37. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89:E1-E7.
38. Chang EI, Loh SA, Ceradini DJ, Chang EI, Lin SE, Bastidas N, et al: Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1α stabilization during ischemia. Circulation 2007; 116: 2818-2829.
39. Chu K, Jung KH, Lee ST, Park HK, Sinn DI, Kim JM, et al: Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke. Stroke 2008; 39: 1441-1447.
40. Sobrino T, Hurtado O, Moro MA, Rodríguez- Yáñez M, Castellanos M, Brea D, Moldes O, et al: The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke 2007; 38: 2759-2764.